Alk-Abello ASWBO:ALKB -0.12%66 Pretax Margin % is 32.92% as of Mar. 2026, which is 286% above its 10-year median of 8.52. GuruFocus rates WBO:ALKB with a GF Score™ of 66/100 and a GF Value™ of €27.26 (Modestly Overvalued). The stock has 5 warning signs investors should review. Among 946 Biotechnology companies, Alk-Abello AS ranks better than 89.32% on this metric.
Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Alk-Abello AS's Pre-Tax Income for the
three
months ended in Mar. 2026 was €78.0 Mil. Alk-Abello AS's Revenue for the
three
months ended in Mar. 2026 was €236.9 Mil. Therefore, Alk-Abello AS's pretax margin for the quarter that ended in Mar. 2026 was 32.92%.
The historical rank and industry rank for Alk-Abello AS's Pretax Margin % or its related term are showing as below:
WBO:ALKB'
s Pretax Margin % Range Over the Past 10 Years
Min: -4.19 Med: 8.52 Max: 26.6
Current: 26.6
WBO:ALKB's Pretax Margin % is ranked better than 89.32% of 946
companies
in the Biotechnology industry
Industry Median: -90.5
vs WBO:ALKB: 26.60
Alk-Abello AS (WBO:ALKB) Pretax Margin % Explanation
The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.
The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.
It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.
The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.
Alk-Abello AS Pretax Margin % Related Terms
Alk-Abello AS Pretax Margin % Historical Data
* Premium members only.
The historical data trend for Alk-Abello AS's Pretax Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:ALKB vs VRTX, REGN, ALNY: Pretax Margin % Comparison
For the Biotechnology subindustry, Alk-Abello AS's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Alk-Abello AS Pretax Margin % vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Alk-Abello AS's Pretax Margin % distribution charts can be found below:
* The bar in red indicates where Alk-Abello AS's Pretax Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Alk-Abello AS (WBO:ALKB) has a Pretax Margin % of 32.92% as of Mar. 2026. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Alk-Abello AS and its competitors. This is 286% above median its historical median of 8.52. According to the industry distribution chart, Alk-Abello AS ranks #101 out of 946 companies in the Biotechnology industry, placing it in the top 10.7%.
Is Alk-Abello AS's Pretax Margin % too high?
Alk-Abello AS's current Pretax Margin % of 32.92% is 286% above median its 10-year median of 8.52. Based on the distribution chart, Alk-Abello AS ranks #101 out of 946 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Alk-Abello AS has a GF Score™ of 66/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Alk-Abello AS's Pretax Margin % compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Alk-Abello AS ranks #101 out of 946 companies for Pretax Margin %. This places Alk-Abello AS in the top 11% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pretax Margin % for a Biotechnology company?
A good Pretax Margin % depends on the Biotechnology industry context. However, Pretax Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pretax Margin % mean?
A high Pretax Margin % can signal that a stock is expensive relative to its fundamentals. Pre-Tax margin is the ratio of total pre-tax income to net sales. View historical data on Alk-Abello AS and its competitors. Alk-Abello AS's current Pretax Margin % is 32.92%, which is 286% above median its own 10-year median of 8.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alk-Abello AS stock overvalued right now?
Based on GuruFocus' analysis, Alk-Abello AS (WBO:ALKB) is currently considered Modestly Overvalued. The stock's GF Value™ is €27.26, compared to a current price of €34.22 — trading 25.5% above its estimated fair value. The current Pretax Margin % is 32.92%, which is 286% above median its 10-year median of 8.52. Alk-Abello AS's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pretax Margin % calculated?
Pretax Margin % is calculated from a company's financial statements. For Alk-Abello AS (WBO:ALKB), the current Pretax Margin % is 32.92% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Alk-Abello AS (WBO:ALKB) Overvalued in 2026?
Based on GuruFocus' analysis, Alk-Abello AS stock appears to be overvalued.
The current stock price of €34.22 is trading 25.5% above its estimated GF Value™ of €27.26.
GuruFocus considers Alk-Abello AS to be Modestly Overvalued.
Key valuation signals for WBO:ALKB:
Pretax Margin %: 32.92% (286% above median its 10-year median of 8.52)
GF Value™: €27.26 vs. price of €34.22 (25.5% above fair value)
No single metric tells the full story. See the WBO:ALKB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Alk-Abello AS is a biotechnology company that focuses on pharmaceutical prevention, diagnosis, and treatment of allergies. The company is focused on respiratory diseases, including allergic rhinitis and allergic asthma. Moreover, the firm specializes in venom immunotherapy for patients suffering from bee and wasp allergies. The company's treatments induce a protective immune response that provides sustained symptom relief. Its primary focus is on allergy patients whose disease is not well controlled, despite the use of symptom-relieving medication. The company operates in Europe, North America and International Markets. It derives maximum revenue from Europe.
66GF Score
Get the complete analysis for WBO:ALKB
Pretax Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:ALKB has been successfully added to your 
